Contraceptive devices market seen reaching $18.31 billion by 2030

The contraceptive devices market is projected to grow from $14.4 billion in 2026 to $18.31 billion by 2030, according to a new report from The Business Research Company. Rising STI rates, broader reproductive health access and demand for long-acting options are among the main forces behind the outlook.

Why it matters: - The contraceptive devices market is moving higher as demand rises for pregnancy prevention and STI protection. - The market's forecast growth signals more spending on reproductive health products, online distribution and long-acting contraceptive options. - The report points to a 6.2% CAGR through 2030, which suggests steady global expansion rather than a short-lived spike.

What happened: - The Business Research Company released its contraceptive devices market report on Aug. 1, 2026. - The report values the market at $14.4 billion in 2026. - The report forecasts the market will reach $18.31 billion by 2030. - The report says the market grew from $13.55 billion in 2025 to $14.4 billion in 2026, a 6.3% CAGR. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - Contraceptive devices are medical tools designed to prevent pregnancy and, in some cases, reduce STI risk. - The report cites increased awareness of family planning, government population control efforts, unintended pregnancy rates, expanded reproductive health services and wider access to over-the-counter products as drivers of recent growth. - Future growth is expected to come from stronger emphasis on reproductive rights and women's health. - The report also points to rising interest in long-term and low-maintenance contraceptive options. - Digital health platforms and online pharmacies are expected to expand access. - Male contraceptive methods are gaining acceptance. - Public organizations and NGOs are increasing sexual health outreach. - Key trends include wider use of long-acting reversible contraceptives. - The report also flags rising demand for female-controlled contraceptive choices. - Non-hormonal methods are gaining acceptance. - Dual protection against pregnancy and STIs is becoming a bigger focus. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company added market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics to its 2026 reports. - The report offers a free sample at Download a free sample of the contraceptive devices market report. - The full report is available at View the full contraceptive devices market report.

Between the lines: - The report's growth case is tied not just to pregnancy prevention, but to broader sexual health concerns. - Rising STI diagnoses strengthen the business case for barrier methods such as condoms. - The report cites UK Health Security Agency data showing England recorded 401,800 new STI diagnoses in 2023, up 4.7% from 383,789 in 2022. - Gonorrhea diagnoses in England rose 7.5% to 85,223 in 2023 from 79,268 in 2022. - Infectious syphilis cases in England rose 9.4% to 9,513 in 2023 from 8,693 in 2022. - The fastest-growing areas appear to be products and channels that reduce friction for users, including long-acting methods, online sales and public health distribution.

What's next: - The report expects market growth to continue through 2030 at a 6.2% CAGR. - Asia-Pacific's growth trajectory could narrow the gap with North America if healthcare investment and reproductive health awareness keep rising. - Demand for non-hormonal, female-controlled and dual-protection products is likely to shape product development and marketing strategies. - The report's forecasting tools and regional analysis are positioned to help suppliers and investors track the next phase of market expansion.